15-50958637-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_007347.5(AP4E1):c.1694C>T(p.Ala565Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000216 in 1,614,132 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007347.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP4E1 | NM_007347.5 | c.1694C>T | p.Ala565Val | missense_variant | 14/21 | ENST00000261842.10 | NP_031373.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AP4E1 | ENST00000261842.10 | c.1694C>T | p.Ala565Val | missense_variant | 14/21 | 1 | NM_007347.5 | ENSP00000261842.5 | ||
AP4E1 | ENST00000560508.1 | c.1469C>T | p.Ala490Val | missense_variant | 14/21 | 1 | ENSP00000452976.1 | |||
AP4E1 | ENST00000558439.5 | n.*818C>T | non_coding_transcript_exon_variant | 14/21 | 1 | ENSP00000452712.1 | ||||
AP4E1 | ENST00000561393.5 | n.*738C>T | non_coding_transcript_exon_variant | 13/20 | 1 | ENSP00000452711.1 | ||||
AP4E1 | ENST00000558439.5 | n.*818C>T | 3_prime_UTR_variant | 14/21 | 1 | ENSP00000452712.1 | ||||
AP4E1 | ENST00000561393.5 | n.*738C>T | 3_prime_UTR_variant | 13/20 | 1 | ENSP00000452711.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152176Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000231 AC: 58AN: 251322Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135824
GnomAD4 exome AF: 0.000222 AC: 324AN: 1461838Hom.: 1 Cov.: 31 AF XY: 0.000241 AC XY: 175AN XY: 727220
GnomAD4 genome AF: 0.000164 AC: 25AN: 152294Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74470
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 565 of the AP4E1 protein (p.Ala565Val). This variant is present in population databases (rs142762839, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with AP4E1-related conditions. ClinVar contains an entry for this variant (Variation ID: 568340). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Neurodevelopmental delay Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Kariminejad - Najmabadi Pathology & Genetics Center | Sep 01, 2018 | - - |
Hereditary spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Jan 28, 2022 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2022 | AP4E1: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at